<?xml version="1.0" encoding="UTF-8"?>
<p>Vaccinations provide an effective means of protection from infectious diseases for humans and animals. Nevertheless, reactive vaccine developments are driven only by outbreaks, and epidemics leave populations at-risk for re-emerging diseases. This has been highlighted by recent epidemics by the arthropod-borne viruses (arboviruses) Chikungunya [
 <xref rid="B1-vaccines-08-00273" ref-type="bibr">1</xref>] and Zika [
 <xref rid="B2-vaccines-08-00273" ref-type="bibr">2</xref>]. The coronavirus vaccine development is another example, where an investment in a forward-looking vaccine design could help to prevent new outbreaks, rather than responding only when the latest viral outbreak emerges as a threat to global health, which delays the development of an effective vaccination countermeasure [
 <xref rid="B3-vaccines-08-00273" ref-type="bibr">3</xref>,
 <xref rid="B4-vaccines-08-00273" ref-type="bibr">4</xref>,
 <xref rid="B5-vaccines-08-00273" ref-type="bibr">5</xref>,
 <xref rid="B6-vaccines-08-00273" ref-type="bibr">6</xref>,
 <xref rid="B7-vaccines-08-00273" ref-type="bibr">7</xref>].
</p>
